NEW YORK, March 12 Reportlinker.com announces that a new market research report is available in its catalogue:
Global Stem Cells Research Industry
Advertisement
http://www.reportlinker.com/p0181100/Global-Stem-Cells-Research-Industry.html
This report analyzes the US Market for Stem Cells Research in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 92 companies including many key and niche players such as Advanced Cell Technology, Inc., Athersys, Inc., BioE, Inc., Cryo-Cell International, Inc., Cytori Therapeutics, Inc., Edstrom Biosciences, Inc., Geron Corporation, International Stem Cell Corporation, Neuralstem, Inc., NeuroGeneration, Inc., Osiris Therapeutics, StemCells, Inc., ThermoGenesis Corp., and ViaCord, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Advertisement
STEM CELLS RESEARCH MCP-6142
A US MARKET REPORT
CONTENTS
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITION
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
II. A US MARKET REPORT
1. MARKET OVERVIEW II-1
Overview II-1
Challenges II-1
Stem Cell Therapy Gaining Acceptance II-1
Stem Cells in Drug Discovery II-2
Tools for Drug Development II-2
New Growth Areas II-2
Orthopedic Products - A potential growth sector II-2
Utilitarian Functions of Cord Blood Stem Cells II-2
Umbilical Cord Stem Cells in Treatment of Hepatic Diseases II-3
Human Umbilical Cord Blood-Derived Stem Cells to Synthesize
Insulin II-3
US Market for Stem Cell Research II-3
Table 1: US Recent Past, Current & Future Analysis for Stem
Cell Products with Annual Revenue Figures in US$ Million for
Years 2006 through 2015 (includes corresponding Graph/Chart) II-4
Competitive Scenario II-4
Table 2: Leading Players in the US Stem Cell Therapeutics
Market (2007): Percentage Breakdown of Value Sales for
ViaCell Inc., Cryo-Cell, Osiris Therapeutics Inc.,
International Stem Cell Corporation, Geron Corp., Cytori
Therapeutics Inc., Athersys Inc., and Others (includes
corresponding Graph/Chart) II-4
2. PRODUCT OVERVIEW II-5
Stem Cell Research II-5
Stem Cells - Description II-5
Types of Stem Cells II-5
Embryonic Stem Cells II-5
mES and hES II-5
Adult Stem Cells II-6
Pluripotent Adult Stem Cells II-6
The Stem Cell Line - Cell Division II-7
Stem Cells - Properties II-7
Ability to Renew on its Own II-7
Potency II-7
Definitions of Various Potencies II-8
Identification of Stem Cells II-8
Stem Cells - Applications II-8
History of Stem Cells II-9
Stem Cells - Services and Products II-9
Significance of Stem Cell Products/Services II-10
Technological Developments II-10
3. PRODUCT INNOVATIONS/INTRODUCTIONS II-11
ThermoGenesis to Launch Res-Q System II-11
Invitrogen to Introduce New Technology for Safe Stem Cell
Treatment II-11
Millipore Unveils MilliTrace(TM) Stem Cell Lines II-11
Millipore Unveils ESGRO Complete(TM) PLUS medium II-11
Bayer Launches Reformulated Liquid LeukineŽ II-12
Shenzhen Beike Biotechnology and CMC Launch NBPD's SCRM
Industrial Project II-12
Vitro Unveils New Products Supporting Stem Cell Research II-13
Endogenous Stem Cells Activators Introduces KRONOS IV II-13
ArunA Biomedical and Open Biosystems Launch iPS Kit II-13
Invitrogen Introduces Neon Transfection Device II-13
Invitrogen Introduces Xenogeneic-Free Media II-14
NanoInk Unveils NanoStem Cell Division II-14
Advanced Cell Technology Unveils New Process for Functional
Hepatocytes Generation II-14
4. STRATEGIC CORPORATE DEVELOPMENTS II-15
MedCell Bioscience Merges with NovaThera II-15
Regenetech to Merge with Healthcare of Today II-15
StemCells Acquires Stem Cell Sciences II-15
BioSante Pharmaceuticals Merges with Cell Genesys II-16
Cell Therapeutics Enters into Joint Venture with Spectrum
Pharmaceuticals II-16
Cryo-Cell International Enters into Collaboration with
Cryopraxis Cryobiology II-17
Embryome Sciences Signs Partnership Agreement with
Reproductive Genetics Institute II-17
ENKAM Inks Licensing Agreement with STEMCELL II-18
Sigma-Aldrich Inks Distribution Agreement with AlphaGenix II-18
ThermoGenesis and Celling Technologies Extend Collaboration II-18
Vivalis Enters into Collaboration with SAFC Biosciences II-19
ReNeuron Enters into Agreement with Angel Biotechnology Holdings II-19
Cellartis Signs Agreement with ReproCELL II-20
Cellartis and AstraZeneca Extend Collaboration II-20
Embryome Sciences and Millipore Sign Co-Marketing Agreement II-20
Cytori Enters into Partnership with GE Healthcare II-21
Stemgent Enters into Co-Exclusive Marketing Agreement with
CellDesign II-21
MultiCell Technologies and Maxim Biotech Sign R&D Agreement II-22
GE Healthcare Collaborates with Geron Corporation II-22
Moraga Biotechnology Licenses BLSCs to Pharmacells II-23
CordLife Develops Stem Cell Therapies in India II-23
NsGene Receives European Patent Rights II-24
Pfizer to Invest in Stem Cell Research II-24
SCTI Commences Histostem Products Distribution Process II-24
Geron Secures FDA Approval for Human Trial of Embryonic Stem
Cell-Based Therapy II-25
Applied Biosystems Merges with Invitrogen II-25
Bennett, Coleman and Co Acquires Stake in Stem One Biologicals II-26
BMXP Holdings Acquires Freedom Environmental Services II-26
Saints Capital Completes Neuronyx Acquisition II-26
Intercity Acquires Exordia II-26
iPS and Stem Cell Merge with CDI Merge II-26
Biohellenika Acquires Exclusive Rights of Cytori's StemSource
Cell Bank II-27
International Stem Cell Signs Agreement with Millipore
Corporation II-27
ReNeuron Enters into Agreement with Angel Biotechnology II-28
ThermoGenesis and Celling Technologies Ink a Distribution
Agreement II-28
BioTime and Embryome Ink a Deal with International Stem Cell II-28
Cryo-Cell Enters into Agreement with Saneron II-29
Genzyme Enters into Alliance with Osiris II-29
VivoMedica Enters into Collaboration with Cellartis II-30
Histostem Signs MOU with Stem Cell Therapy II-30
Vantus Inks Agreement with US Davis Center for Equine Health II-31
Stem Cell Sciences Enters into Agreement with Pfizer II-31
Sigma-Aldrich Inks Distribution Agreement with AlphaGenix II-31
Cellartis Signs Agreement with Pfizer II-32
Ortec Changes Corporate Name to Forticell Bioscience II-32
FDA Grants Approval to Genzyme's Mozobil II-33
Pfizer Inaugurates Pfizer Regenerative Medicine Research Facility II-33
Stem Cell Therapeutics Receives Australian Patent II-33
STEMCELL Technologies Secures License Rights to Geron IP II-34
BioTime Starts Embryonic Stem Cell Solution Facility II-34
Geron Successfully Transplants Pancreatic Islet-Like Clusters II-35
StemCells Secures US Patent II-35
5. FOCUS ON SELECT US PLAYERS II-36
Advanced Cell Technology, Inc. II-36
Athersys, Inc. II-36
BioE, Inc. II-36
Cryo-Cell International, Inc. II-37
Cytori Therapeutics, Inc. II-37
Edstrom Biosciences, Inc. II-37
Geron Corporation II-37
International Stem Cell Corporation II-38
Neuralstem, Inc. II-38
NeuroGeneration, Inc. II-39
Osiris Therapeutics II-39
StemCells, Inc. II-39
ThermoGenesis Corp II-39
ViaCord, LLC II-40
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 92 (including Divisions/Subsidiaries - 96)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 66
Canada 3
Japan 1
Europe 17
France 1
The United Kingdom 9
Spain 1
Rest of Europe 6
Asia-Pacific (Excluding Japan) 8
Middle-East 2
------------------------------------------
To order this report:
Biotechnology Industry: Global Stem Cells Research Industry
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Contact: Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
